Scientific and corporate news

Scientific News

Outcomes of adipose tissue stem cell transplantation for the treatment of refractory lupus nephritis

To date, the immunomodulatory capacity of mesenchymal stem cells is well known. In this phase one clinical trial, the efficacy of these cells for the treatment of refractory lupus nephritis (LN) was verified. Specifically, 9 patients received systemic infusion of mesenchymal stem cells derived from adipose tissue and followed up for a 12-month follow-up period.

Read More »
Scientific News

Outcomes of mesenchymal stem cell transplantation from umbilical cord for the treatment of decompensated liver cirrhosis

group (n = 111) and cord blood mesenchymal stem cell infusion group (n = 108). Both groups were followed up for a follow-up period of 7 years (October 2010 to October 2017). Specifically, patients in the control group received only conventional therapy while patients in the other group received three infusions of mesenchymal stem cells from cord tissue at four-week intervals.

Read More »
Scientific News

Maternal grandmother’s cells in cord blood

During pregnancy there is a physiological two-way exchange of cells between mother and foetus. Similarly, expectant mothers may have acquired cells from their mothers (GdM) and these latter cells may in turn be transferred to the fetus through the mother-fetus blood stream.

Read More »